Histone deacetylase inhibitors: current status and overview of recent clinical trials

X Ma, HH Ezzeldin, RB Diasio - Drugs, 2009 - Springer
Histone deacetylase (HDAC) inhibitors are a new group of anticancer agents that have a
potential role in the regulation of gene expression, induction of cell death, apoptosis and cell …

[引用][C] Histone Deacetylase Inhibitors: Current Status and Overview of Recent Clinical Trials

X MA, HH EZZELDIN, RB DIASIO - Drugs (Basel), 2009 - pascal-francis.inist.fr
Histone Deacetylase Inhibitors: Current Status and Overview of Recent Clinical Trials CNRS
Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search …

Histone Deacetylase Inhibitors

X Ma, HH Ezzeldin, RB Diasio - Drugs, 2009 - search.proquest.com
Histone deacetylase (HDAC) inhibitors are a new group of anticancer agents that have a
potential role in the regulation of gene expression, induction of cell death, apoptosis and cell …

Histone deacetylase inhibitors: current status and overview of recent clinical trials

X Ma, HH Ezzeldin, RB Diasio - Drugs, 2009 - pubmed.ncbi.nlm.nih.gov
Histone deacetylase (HDAC) inhibitors are a new group of anticancer agents that have a
potential role in the regulation of gene expression, induction of cell death, apoptosis and cell …

Histone deacetylase inhibitors: current status and overview of recent clinical trials.

X Ma, HH Ezzeldin, RB Diasio - Drugs, 2009 - europepmc.org
Histone deacetylase (HDAC) inhibitors are a new group of anticancer agents that have a
potential role in the regulation of gene expression, induction of cell death, apoptosis and cell …

[PDF][PDF] Histone Deacetylase Inhibitors

X Ma, HH Ezzeldin, RB Diasio - Drugs, 2009 - researchgate.net
Histone deacetylase (HDAC) inhibitors are a new group of anticancer agents that have a
potential role in the regulation of gene expression, induction of cell death, apoptosis and cell …

Histone deacetylase inhibitors: Current status and overview of recent clinical trials

X Ma, HH Ezzeldin, RB Diasio - Drugs, 2009 - mayoclinic.elsevierpure.com
Histone deacetylase (HDAC) inhibitors are a new group of anticancer agents that have a
potential role in the regulation of gene expression, induction of cell death, apoptosis and cell …

[引用][C] Histone Deacetylase Inhibitors

X Ma, HH Ezzeldin, RB Diasio - Drugs, 2009 - cir.nii.ac.jp

Histone deacetylase inhibitors: Current status and overview of recent clinical trials

X Ma, HH Ezzeldin, RB Diasio - Drugs, 2009 - mayoclinic.pure.elsevier.com
Histone deacetylase (HDAC) inhibitors are a new group of anticancer agents that have a
potential role in the regulation of gene expression, induction of cell death, apoptosis and cell …

Histone Deacetylase Inhibitors.

X Ma, HH Ezzeldin, RB Diasio - Drugs, 2009 - search.ebscohost.com
Histone deacetylase (HDAC) inhibitors are a new group of anticancer agents that have a
potential role in the regulation of gene expression, induction of cell death, apoptosis and cell …